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Abstract
Activity of voltage-gated potassium (Kv) channels controls membrane potential, which
subsequently regulates cytoplasmic free calcium concentration ([Ca2+]cyt) in pulmonary
artery smooth muscle cells (PASMCs). Acute hypoxia inhibits Kv channel function in
PASMCs, inducing membrane depolarization and a rise in [Ca2+]cyt that triggers vaso-
constriction. Prolonged hypoxia inhibits expression of Kv channels and reduces Kv channel
currents in PASMCs. The consequent membrane depolarization raises [Ca2+]cyt, thus
stimulating PASMC proliferation. The present review discusses recent evidence for the
involvement of Kv channels in initiation of hypoxic pulmonary vasoconstriction and in chronic
hypoxia-induced pulmonary hypertension.
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[Ca2+]cyt = cytoplasmic calcium concentration; Em = membrane potential; HPV = hypoxic pulmonary vasoconstriction; IK(V) = potassium currents
through potassium channels; KCa = calcium-activated potassium channel; KATP = ATP-sensitive potassium channel; Kv = voltage-gated potassium
channel; NO = nitric oxide; PASMC = pulmonary artery smooth muscle cell; SMC = smooth muscle cell; VDCC = voltage-dependent calcium
channel.
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Introduction
The main function of the low-pressure, low-resistance pul-
monary circulation is to oxygenate blood to be supplied to
the rest of the body. In order to perform this function effi-
ciently, the lung must match its regional ventilation and
perfusion. Thus, in regions where alveolar oxygen levels
are low the pulmonary arteries constrict, diverting blood
flow to better ventilated areas of the lung where gas
exchange can take place more efficiently. This important
physiologic phenomenon is known as ‘hypoxic pulmonary
vasoconstriction’ (HPV), and is unique to the pulmonary
circulation; hypoxia generally causes dilatation in systemic
arterial beds.
In the fetus, gas exchange occurs via the placenta and
HPV acts to maintain a high pulmonary vascular resistance
to divert blood flow away from the lungs through the
ductus arteriosus. In the adult, HPV can act as a protec-
tive mechanism during acute exposure to hypoxia in order
to maintain ventilation–perfusion matching (eg during an
acute asthma attack). Chronic exposure to hypoxia (eg
chronic obstructive pulmonary disease or living at highhttp://respiratory-research.com/content/1/1/040
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altitude) causes continuous alveolar hypoxia, which results
in sustained HPV, leading to vascular remodeling, pulmonary
hypertension, and possibly right heart failure and death.
The mechanism that is responsible for HPV has still not
been fully elucidated. The present review concentrates
specifically on summarizing the knowledge gained, during
the past 10 years, regarding the role of Kv channels in ini-
tiation of the acute and chronic responses of pulmonary
arteries to hypoxia. Also briefly summarized are some of
the mechanisms that underlie current treatment of hypoxia-
related cardiopulmonary disease states.
Acute hypoxic pulmonary vasoconstriction
In whole animals, or isolated lungs, acute exposure to
hypoxia causes a sustained increase in pulmonary arterial
pressure. Hypoxia also causes contraction in isolated pul-
monary arteries [1–3] and single PASMCs [4,5]. In con-
trast, hypoxia causes relaxation of cerebral arterial smooth
muscle cells (SMCs) [4]. These findings indicate that the
mechanism of HPV is intrinsic to the vascular wall of pul-
monary arteries, and imply that the effects of neural inputs,
blood-borne agents, and lung parenchyma do not directly
mediate HPV, but rather they modulate the response.
Removal of the endothelium does not abolish hypoxia-
mediated contraction in isolated pulmonary arteries [3].
The observations of hypoxia-induced contraction in single
PASMCs imply that the endothelium is not necessary for
HPV, and that all of the mechanisms that are necessary for
sensing and responding to hypoxia are intrinsic to the
PASMC [4,5]. It is generally accepted that the endothe-
lium does modulate HPV. This effect could be achieved
through release of endothelium-derived contracting
factors (eg endothelin-1 or thromboxane A2) or through
reduction of vasodilator activity of endothelium-derived
relaxing factors (eg nitric oxide [NO] and prostacyclin) and
endothelium-derived hyperpolarizing factors. 
Role of intracellular calcium
An increase in [Ca2+]cyt is necessary to elicit contraction in
smooth muscle. In PASMCs, [Ca2+]cyt can be increased
by calcium influx through sarcolemmal calcium channels
and by its release from intracellular stores (mainly sar-
coplasmic reticulum). There are at least three classes of
calcium-permeable channels in the plasma membrane:
voltage-dependent calcium channels (VDCCs), receptor-
operated calcium channels, and store-operated calcium
channels. Calcium influx through VDCCs is governed by
the membrane potential (Em). VDCCs are normally closed
at resting Em, but when the membrane is depolarized they
open, allowing calcium influx into the cells [6,7].
McMurtry et al [8] demonstrated that blockers of calcium
channels reduced the hypoxic response in isolated lungs,
indicating that a rise in [Ca2+]cyt is a necessary step in
HPV. Subsequent studies in isolated PASMCs, using fluo-
rescence microscopy techniques, have shown that
hypoxia does cause an increase in [Ca2+]cyt [9,10]. This
increase in [Ca2+]cyt is smaller in the absence of extracel-
lular calcium, implying contributions from calcium release
from intracellular stores and calcium entry across the sar-
colemma. The partial inhibition of HPV by the VDCC
blocker verapamil [8] suggested that hypoxia must cause
opening of VDCCs, implying that membrane depolariza-
tion would also appear to be a necessary step in the
hypoxic response. Harder et al [1] and Madden et al [2]
demonstrated that hypoxia does indeed induce membrane
depolarization and elicits calcium-dependent action poten-
tials in cat pulmonary arteries.
Taken together, the results of these studies indicate that
initial depolarization is necessary for opening of VDCCs to
allow influx of calcium into PASMCs and to elicit HPV.
They also imply that one or more of the potassium channels
involved in regulating Em in PASMCs must be sensitive to
hypoxia, and could be involved in initiating HPV. These find-
ings have led to a considerable body of research con-
cerned with identifying the particular potassium channel(s)
that are involved and the mechanism by which changes in
oxygen tension are sensed by the channel(s).
Regulation of membrane potential in pulmonary artery
smooth muscle cells
Em in vascular SMCs is predominantly controlled by potas-
sium permeability, which is determined by sarcolemmal
potassium channel conductance and transmembrane
potassium gradient. Intracellular potassium concentration
(140 mmol/l) is greater than that of extracellular potassium
(5 mmol/l), favoring movement of potassium out of the cell
when potassium channels are open, leading to hyperpolar-
ization of the membrane. Closure of these channels would
cause membrane depolarization, leading to opening of
VDCCs and entry of calcium into the cell. To date, three
types of potassium channels have been described in
PASMCs: Kv channels [7,11•,12•], calcium-activated
potassium (KCa) channels [13,14], and ATP-sensitive
potassium (KATP) channels [6]. Potassium currents
through all three of these channel types contribute to the
regulation of Em [6]. Using the Kv channel blocker 4-
aminopyridine, it has been shown [7,9,11•,12•,15] that
potassium currents through Kv channels (IK(V)) are the
major determinants of resting Em in PASMCs.
Effect of hypoxia on IK(V)
Post et al [16••] first demonstrated that hypoxia reduced
potassium currents in canine PASMCs, and others have
since shown a similar effect of hypoxia on potassium cur-
rents in PASMCs from other animals [17,18••,19••]. There
is now wide agreement that the current inhibited by acute
hypoxia is IK(V) [12•,17,18••,19••]. Fig. 1 summarizes the
effects of acute hypoxia on whole-cell IK(V),  Em, andRespiratory Research    Vol 1 No 1 Sweeney and Yuan
[Ca2+]cyt in PASMCs. Reduction in perfusate oxygen
tension from 135–145 mmHg to 10–35 mmHg signifi-
cantly reduces IK(V) in PASMCs (Fig. 1a and b). The resul-
tant membrane depolarization leads to opening of VDCCs,
allowing calcium influx into the cells to increase [Ca2+]cyt
(Fig. 1c and d). This hypoxic inhibition of IK(V) is selective
to PASMCs, because acute hypoxia has negligible effects
on IK(V) in mesenteric arterial SMCs (Fig. 1b).
Molecular identity of Kv channels
At the molecular level, Kv channels are homo- or hetero-
multimeric tetramers that are composed of two structurally
distinct subunits: the pore-forming a-subunits and the reg-
ulatory b-subunits. The genes that encode functional Kv
channel a-subunits fall into four subfamilies: Shaker (Kv1),
Shab (Kv2), Shaw (Kv3), and Shal (Kv4). At least 25 ver-
tebrate genes that encode functional Kv channel a-sub-
units have been isolated from mammals, and more than 15
genes from humans. Each of these Kv channel a-subunits
produces functionally distinct Kv channels. Recently, four
new subfamilies of electrically silent Kv channel a-subunits
have been cloned: Kv5, Kv6, Kv8, and Kv9. Expression of
these modulatory a-subunits  per se does not produce
potassium channel activity; however, coexpression of
these modulatory a-subunits with other functional Kv
channel  a-subunits (eg Kv2.1) significantly modulates bio-
physical properties (eg activation and inactivation kinetics,
voltage dependence) and expression levels of the func-
tional Kv channels [20••].
Three subfamilies of Kv channel b-subunits – Kvb1, Kvb2,
and Kvb3 – have been identified in mammalian tissues
[21,22]. Although expression of a-subunits alone is suffi-
cient to generate Kv channels that possess many features
of the corresponding channels in situ, studies on native
channels have confirmed that the biophysical properties of
Kv channels encoded by certain a-subunits can be dra-
matically altered by their association with b-subunits. For
example, association of b-subunits with a-subunits can
confer fast inactivation on slowly inactivating or noninacti-
vating delayed rectifier Kv channels [22], and determines
the response of the a-subunits to activated protein
kinases. In addition to changing kinetic properties of Kv
channels, b-subunits can also reduce IK(V) as an open-
channel blocker.
Molecular identity of the Kv channels that are responsible
for the hypoxia-sensitive IK(V)
The potential candidate Kv channel a-subunits that could
form oxygen-sensitive, homomeric or heteromeric chan-
nels include Kv1.2 [23•,24••,25••], Kv1.5 [25••,26], Kv2.1
[20••,24••,26], Kv3.1 [27•], Kv4.2 [28•], and Kv9.3
[20••,24••]. It has recently been reported that the Kvb1
subunits, which specifically bind to the Shaker (Kv1)
channel a-subunits, belong to an NAD(P)H-dependent
oxidoreductase superfamily, suggesting that the b-sub-
units might play a critical role in sensing changes in redox
status [22] and oxygen tension [28•].
A number of studies have determined the properties, includ-
ing sensitivity to hypoxia, of channels formed by recombi-
nant Kv channel subunits expressed in heterologous
systems. Expression of Kv2.1 or coexpression of Kv2.1 with
Kv9.3 (an electrically silent Kv a-subunit) in COS cells
causes Em hyperpolarization [20••]. Hypoxia decreases the
IK(V) generated by either Kv2.1 or Kv2.1/Kv9.3 channels
Figure 1
Effects of acute hypoxia on whole-cell IK(V), Em, and [Ca2+]cyt in
PASMCs. (a) Representative families of currents elicited by
depolarizing the cell to test potentials ranging from –50 to +80 mV in
10-mV increments (holding potential –70 mV); these were recorded
before, during, and after reduction of partial oxygen tension (PO2)i n
the extracellular solution from 149 to 8 mmHg. (b) Summarized data
showing the effect of acute hypoxia (Hyp) on IK(V), elicited by a test
pulse of +60 mV, in PASMCs and mesenteric artery smooth muscle
cells (MASMCs). Data are expressed as mean ± standard error. 
***P < 0.001 versus normoxia (Nor). (c) Change in Em recorded in a
PASMC on switching from normoxic to hypoxic bath solutions. 
(d) [Ca2+]cyt measured (using Fura-2) in a peripheral cytoplasmic
region of a PASMC on switching from normoxic to hypoxic bath
solutions. The PO2 level was measured using an oxygen meter
positioned in the tissue chamber. Modified with permission from 
Yuan et al [19••].transfected in COS or mouse L cells [20••,24••]. The current
generated by either Kv2.1 or Kv2.1/Kv9.3 channels is also
decreased by reduction in intracellular ATP [20••]. Because
the Kv channels contain phosphorylation sites, these effects
on IK(V) may be related to phosphorylation of the channel
(Kv1.2 and/or Kv9.3) protein [20••]. Hypoxia also signifi-
cantly decreases IK(V) in the following: COS cells transiently
transfected with Kv3.1b channels [27•]; PC12 cells or
Xenopus oocytes transfected with Kv1.2 [23•]; and
HEK293 cells cotransfected with Kv4.2 and Kvb1.2 [28•].
Using reverse transcription polymerase chain reaction and
Western blotting, Yuan et al [15] demonstrated the expres-
sion of Kv1.1, Kv1.2, Kv1.4, Kv1.5, Kv1.6, Kv2.1, Kv4.3,
Kv9.3, Kvb1.1, Kvb1.2, and Kvb2.1 in rat PASMCs. Other
groups have confirmed many of these findings and have
further identified the presence of Kv1.3 and Kv3.1 in
PASMCs isolated from rats [20••,26,27•]. Intracellular appli-
cation of the antibody against Kv2.1 reduces whole-cell IK(V),
depolarizes Em, and raises [Ca2+]cyt in PASMCs, whereas
the antibody against Kv1.5 reduces IK(V) and selectively
inhibits the hypoxia-induced increase in [Ca2+]cyt and pul-
monary vasoconstriction [26]. Taken together, these obser-
vations suggest that the homomeric Kv channels formed by
Kv1.2, Kv1.5, Kv2.1, or Kv3.1b, and the heteromeric chan-
nels formed by Kv1.2/Kv1.5, Kv2.1/Kv9.3, or Kv4.2/Kvb1.2
are potential molecular components in hypoxia-induced
membrane depolarization and HPV. Table 1 summarizes
some of the biophysical properties of these channels.
Many of the Kv channel a- and b-subunits identified in
PASMCs, which are potentially involved in forming oxygen-
sensitive Kv channels, including Kv1.2, Kv1.3, Kv1.4,
Kv1.5, Kv2.1, Kv9.3, Kvb1.1, Kvb1.2, and Kvb2.1, are also
expressed in mesenteric arterial SMCs [29]. Qualitative dif-
ferences in Kv channel a-subunits between PASMCs and
systemic artery SMCs have not thus far been observed, but
their divergent responses to hypoxia have been well docu-
mented. Therefore, why hypoxia only inhibits the aforemen-
tioned Kv channels in PASMCs, but not in systemic artery
smooth muscle requires further investigation.
Possible mechanisms involved in oxygen sensing
Kv channels have also been implicated in sensing hypoxia
in other oxygen-sensitive cells, including cells of the carotid
and aortic bodies and neuroepithelial cells [30]. Multiple
pathways may exist for hypoxia-induced Kv channel inhibi-
tion, and the mechanisms of hypoxia-induced inhibition of
potassium currents in oxygen-sensitive cells may be similar.
Acute hypoxia may inhibit Kv channel function by the fol-
lowing mechanisms: inhibiting oxidative phosphorylation
[31]; changing redox status [17,28•,31]; altering a
membrane-delimited oxygen-sensitive regulatory moiety
that is adjacent or coupled to the channel protein [30,32];
activating mitochondrial NAD(P)H oxidase and increasing
superoxide production [33,34]; inhibiting cytochrome
P450 [7]; decreasing intracellular pH [35]; releasing
calcium from intracellular stores [8,12•]; and affecting
directly the Kv channel protein [30]. 
http://respiratory-research.com/content/1/1/040
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Table 1
Biophysical properties of Kv channel a a- and b b-subunits that are potentially involved in oxygen sensing
Subunit Channel conductance (pS) Threshold of activation (mV) Sensitivity to hypoxia References
Kv1.2 18 –20 Yes [24••]
–40 Yes [23•]
Kv1.5 7.1 –50 – [49]
–30 No [27•]
–60 No [24••]
– Yes [26]
Kv2.1 8.5 –10 Yes [20••]
–45 No [23•]
–40 Yes [24••]
Kv3.1b 14–31 –20 Yes [27•]
Kv4.2 – –40 Yes [28•]
Kv1.2/Kv1.5 – –50 Yes [24••]
Kv2.1/Kv9.3 14.5 –50 Yes [20••]
–50 Yes [24••]
Kv4.2/Kvb1.2 – –40 Yes [28•]Respiratory Research    Vol 1 No 1 Sweeney and Yuan
Chronic hypoxic pulmonary vasoconstriction:
role of Kv channels
In lungs from chronically hypoxic rats, the pressor
response to acute hypoxia is impaired, whereas the
pressor response to vasoconstrictor agonists (eg
angiotensin II, prostaglandin F2a, and norepinephrine) is
enhanced [36]. These observations suggest that the
reduced pressor response to acute hypoxia in chronically
hypoxic rats may result from abnormalities in the mecha-
nism that couples acute hypoxia to contraction of the pul-
monary vascular smooth muscle. That is, chronic
hypoxia-mediated pulmonary hypertension may involve the
same mechanisms as those responsible for acute HPV.
Accordingly, a reduction in the activity of Kv channels in
PASMCs, with the resultant membrane depolarization,
may be involved in the development of chronic hypoxia-
mediated pulmonary hypertension by mediating pulmonary
vasoconstriction and vascular remodeling through
increased [Ca2+]cyt in PASMCs.
Fig. 2 illustrates the effects of prolonged hypoxia on
expression of some of the Kv channel subunits in rat
PASMCs. Chronic hypoxia downregulates the mRNA
expression of pore-forming Kv channel a-subunits, includ-
ing Kv1.1, Kv1.2, Kv1.4, Kv1.5, Kv2.1, Kv4.3, and Kv9.3,
in PASMCs (Fig. 2a and b) [25••] (Yu et al, unpublished
data). The inhibitory effect of hypoxia is specific to a-sub-
units because hypoxia has negligible effects on mRNA
expression of the cytoplasmic regulatory b-subunits,
including Kvb1.1, Kvb1.2, and Kvb2.1 (Fig. 2b) [25••].
Consistent with its inhibitory effect on Kv channel expres-
sion, prolonged hypoxia reduces IK(V) (Fig. 3a and b) and
depolarizes PASMCs (Fig. 3d). The resultant increase in
[Ca2+]cyt in PASMCs (Golovina and Yuan, unpublished
data) may serve as an important trigger for pulmonary
vasoconstriction and as a critical stimulus for PASMC pro-
liferation during chronic hypoxia. Similar results have also
been observed in freshly dissociated PASMCs isolated
from chronically hypoxic animals [37••,38,39].
Chronic hypoxia has little effect on systemic arterial pres-
sure, measured via a catheter positioned in the carotid
artery (Yuan, unpublished data). In mesenteric arterial
SMCs, chronic hypoxia did not significantly alter the expres-
sion of the Kv channel a- or b-subunits examined (Fig. 2d;
Yu and Yuan, unpublished data). Also, in these cells IK(V)
was slightly increased (Fig. 3c) and Em was hyperpolarized
(Fig. 3d; Platoshyn and Yuan, unpublished data).
Cellular and molecular mechanisms mediating the effects
of chronic hypoxia
As discussed above, it appears that hypoxia regulates the
function of Kv channel a-subunits via an intrinsic mecha-
nism that exists uniquely in PASMCs. The selectivity of
hypoxia-induced downregulation of Kv channel expression
and reduction in IK(V) in PASMCs suggests that the molec-
ular mechanisms involved in the regulation of Kv channel
gene expression are quite different between pulmonary
and systemic arterial SMCs.
The common pathways that transduce hypoxic signals from
the sensor to appropriate gene expression involve phos-
phorylation and/or redox modification of responsive tran-
scription factors [40]. Hypoxia can modulate a variety of
transcription factors and signal transduction signaling pro-
teins, such as HIF-1, nuclear factor-kB, c-fos/c-jun, p53,
KBF, c/EBP, FixL, and FixJ, suggesting that a large number
of transcriptional systems contribute to the response to
hypoxia [40–42].
Chronic hypoxia may inhibit Kv channel activity by directly
or indirectly downregulating mRNA and protein expression
of Kv channel a-subunits. In addition to the mechanisms by
which acute hypoxia decreases Kv channel activity, the
underlying mechanisms that are involved in chronic
hypoxia-induced reduction in Kv channel expression may
Figure 2
Effects of prolonged hypoxia on mRNA and protein levels of Kv
channel a- and b-subunits, in PASMCs and mesenteric artery smooth
muscle cells (MASMCs). (a) Polymerase chain reaction-amplified
products for Kv1.2 (295 bp) and b-actin (244 bp) displayed in agarose
gel. PASMCs were incubated in normoxia (Nor) and hypoxia (25–35
mmHg) for 24 h (H24), 36 h (H36), 48 h (H48), and 60 h (H60). 
(b) mRNA levels (mean ± standard error) of Kv1.2, Kv1.4, Kv1.5, and
Kvb1.1 in PASMCs, normalized to the amount of b-actin. (c) Western
blot analysis of Kv1.2 channel proteins from PASMCs incubated in
normoxia (Nor) and hypoxia (25–35 mmHg) for 48 h (H48), 60 h
(H60), and 72 h (H72). (d) mRNA levels (mean ± standard error),
normalized to the respective amounts of b-actin, in PASMCs (left
panel) and MASMCs (right panel) before (Nor) and after (Hyp)
treatment with hypoxia. **P < 0.01 versus Nor. M, 100-bp DNA ladder.
Modified with permission from Wang et al [25••].include the following: upregulation or downregulation of
the transcription factors and signal transduction proteins
[40] that can directly bind to the Kv channel gene promot-
ers (eg Kv1.5 repressor element) and modulate the Kv
channel gene transcription [41,42]; and induction of tran-
scription factors that upregulate intermediate inhibitors of
the Kv channel genes, such as endothelin-1 [38,39].
Preliminary results from our laboratory (Platoshyn et al,
unpublished data) have shown that overexpression of c-jun
significantly decreased whole-cell IK(V) in rat PASMCs.
Whether the hypoxia-sensitive transcription factors have
direct and/or indirect modulatory effects on gene tran-
scription of Kv channels in PASMCs is unclear and
requires further study. Another possibility is that acute
hypoxia decreases IK(V) by inhibiting Kv channel activity in
PASMCs, with the resultant membrane depolarization
attenuating Kv channel expression [43]. The precise
mechanisms that are responsible for the differing effects
of hypoxia on gene expression of Kv channels in pul-
monary and mesenteric artery SMCs may underlie the
upstream regulation of the Kv channel gene promoter.
Therapeutic approaches in hypoxia-mediated
pulmonary hypertension
Acute HPV can be beneficial in vivo, but over a prolonged
period it can be dangerous, leading to persistent elevation
of pulmonary vascular resistance and vascular remodeling,
pulmonary hypertension, right ventricular failure, and pos-
sibly death. Therefore, inhibition of HPV is a potentially
useful therapeutic mechanism for patients with pulmonary
hypertension secondary to hypoxic pulmonary diseases
(eg chronic obstructive pulmonary diseases, Eisen-
menger’s syndrome, and mountain sickness).
Calcium channel blockers
McMurtry et al [8] first showed that the calcium channel
blocker verapamil inhibited HPV in isolated rat lungs.
Membrane depolarization-mediated influx of calcium into
PASMCs during hypoxia is necessary for both vasocon-
striction and cell proliferation. Calcium channel blockers,
which have been shown to inhibit HPV in intact animals
and isolated perfused lungs, have been used clinically
(administered intravenously or orally) to reverse HPV,
because they prevent calcium influx into cells and thus
inhibit pulmonary vasoconstriction. 
Nitric oxide and prostacyclin activate potassium channels
in PASMCs
NO and prostacyclin are potent endothelium-derived relax-
ing factors and inhibitors of SMC proliferation. Inhalation
of NO and intravenous administration of prostacyclin have
been shown to be effective in inhibiting HPV. NO exerts
its vasodilator effect in part by activating KCa and Kv
channels, which subsequently causes membrane hyper-
polarization, decreases resting [Ca2+]cyt, and elicits vaso-
dilatation [44,45]. This activation of KCa and Kv channels
can be directly mediated by the nitrosylation or oxidization
effect on the channel protein, and/or indirectly mediated
by the increase in cGMP production [44,45]. In PASMCs,
NO can also decrease [Ca2+]cyt by the following mecha-
nisms: inhibiting agonist-induced calcium release; blocking
VDCCs; and enhancing calcium extrusion and sequestra-
tion into the sarcoplasmic reticulum. Prostacyclin may
http://respiratory-research.com/content/1/1/040
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Figure 3
Effects of prolonged hypoxia (3 days) on whole-cell IK(V) and resting Em
in PASMCs and mesenteric artery smooth muscle cells (MASMCs).
(a) Representative families of currents, elicited by depolarizing the cell
to a series of test potentials ranging from –40 to +80 mV (holding
potential –70 mV) in PASMCs incubated in normoxia or hypoxia
(25–35 mmHg). (b) and (c) Current–voltage relationship (I–V) curves
(mean ± standard error) of whole-cell IK(V) in (b) PASMCs and (c)
MASMCs incubated in normoxia (¡) or hypoxia (l). (d) Summarized
data (mean ± standard error) showing resting Em in PASMCs and
MASMCs incubated in normoxia (Nor) or hypoxia (Hyp, partial oxygen
tension 25–35 mmHg, for 60 h). ***P < 0.001 versus Nor.cause vasodilatation by partially activating KCa channels in
PASMCs [46]. These results suggest that the therapeutic
effects of NO and prostacyclin may be, at least in part,
due to membrane hyperpolarization induced by enhance-
ment of potassium currents through KCa and Kv channels,
and the subsequent reduction in [Ca2+]cyt in PASMCs.
In animals, endothelin receptor antagonists have been
shown to attenuate acute HPV and reverse or protect
against the development of pulmonary hypertension and
associated vascular remodeling [47]. BQ-123, a specific
endothelin A receptor antagonist, showed selectivity for
the pulmonary circulation, because it did not affect sys-
temic arterial pressure [47]. The action of BQ-123 has
been at least partly attributed to its ability to prevent
endogenous endothelin from inhibiting potassium chan-
nels [39].
Potassium channel openers
Opening of potassium channels is a physiologic mecha-
nism for reversing hypoxia-induced membrane depolariza-
tion, and thereby reversing depolarization-induced
contractions. Synthetic potassium channel openers have
been identified that open KATP or KCa channels. However,
there are not yet specific potassium channel openers for
Kv channels, which are the channels that are actually
inhibited by hypoxia. Lemakalim has been shown to open
KATP channels in PASMCs [6]. Recently, Peng et al [14]
demonstrated that the novel KCa opener dehydroepi-
androsterone, an endogenously produced hormone,
reversed the chronic hypoxia-induced reduction in potas-
sium currents through KCa channels in human PASMCs.
Archer et al [48] demonstrated differential distribution of
potassium channels in pulmonary arteries, with the
smaller resistance arteries, which are most sensitive to
hypoxia, having fewer KCa channels than the conduit pul-
monary arteries. However, because KCa channels have a
large unitary conductance (200–250 pS), opening of only
a few KCa channels would have a significant effect on Em
and would be a very efficient mechanism for reversing
HPV. With the recent advances in molecular identification
of specific potassium channel subunits in PASMCs, it
should soon be possible to design new potassium
channel openers that are selective for specific pulmonary
potassium channels.
The current clinical therapies are aimed at reversing the
pathophysiologic symptoms of hypoxia, which are princi-
pally vasoconstriction and cell proliferation. Current
research is aimed at molecular identification of the
oxygen sensor in the PASMC, and the cellular mecha-
nisms of transduction of the hypoxic signal to effect
HPV and PASMC proliferation. Identification of these
mechanisms should enable the development of new,
selective treatments for hypoxia-related cardiopulmonary
disease states.
Conclusion
Ion channels are involved in regulation of vascular tone in
physiologic and pathophysiologic conditions. Disruption of
[Ca2+]cyt homeostasis, caused by defects in ion channels,
appears to be involved in the pathology of many cardio-
vascular diseases, including hypoxic pulmonary hyperten-
sion. Hypoxia may inhibit Kv channels via multiple
pathways in order to assure the efficacy and sensitivity of
HPV. Acute hypoxia selectively inhibits Kv channel func-
tion and induces Em depolarization in PASMCs, and the
resultant increase in [Ca2+]cyt triggers HPV. Chronic
hypoxia selectively inhibits mRNA and protein expression
of the Kv channel a-subunits (the pore-forming subunits)
and decreases the number of functional Kv channels in
PASMCs. The consequent reduction in IK(V) depolarizes
PASMCs, raises [Ca2+]cyt, and stimulates cell proliferation.
Ultimately, persistent pulmonary vasoconstriction and
excessive vascular remodeling (via medial hypertrophy)
increase pulmonary vascular resistance and cause pul-
monary hypertension. Fig. 4 illustrates schematically the
multiple pathways and modulators that are involved in
effecting the physiologic and pathophysiologic responses
to acute and chronic hypoxia. Further research into the
mechanisms of HPV, the major contributing factor to the
pulmonary hypertension that is present in a variety of
Respiratory Research    Vol 1 No 1 Sweeney and Yuan
Figure 4
Proposed mechanisms involved in HPV and vascular remodeling.
EDRF, endothelium-derived relaxing factor; EDCF, endothelium-derived
constricting factor; PGI2, prostacyclin; ET-1, endothelin-1; [Ca2+]n,
nuclear [Ca2+]; [Ca2+]SR, sarcoplasmic reticulum [Ca2+]; (+), increase;
(–), decrease.cardiopulmonary diseases, should lead to more effective
treatment of these diseases.
Acknowledgments
We apologize to those whose work we have been unable to quote due to
restrictions on space. We gratefully acknowledge the contributions of O
Platoshyn, MS; J Wang, MD; Y Yu, MD, PhD; V Golovina, PhD; and J
Zhang, PhD, to unpublished work cited in this review. This work was sup-
ported by grants from the National Institutes of Health (HL 54043 and HL
64549). Dr J Yuan is an Established Investigator of the American Heart
Association.
References
Articles of particular interest have been highlighted as:
• of special interest
•• of outstanding interest
1. Harder DR, Madden JA, Dawson C: Hypoxic induction of Ca2+-
dependent action potentials in small pulmonary arteries of the cat.
J Appl Physiol 1985, 59:1389–1393.
2. Madden JA, Dawson CA, Harder DR: Hypoxia-induced activation in
small isolated pulmonary arteries from the cat. J Appl Physiol
1985,  59:113–118.
3. Yuan X-J, Tod ML, Rubin LJ, Blaustein MP: Contrasting effects of
hypoxia on tension in rat pulmonary and mesenteric arteries. Am J
Physiol 1990, 259:H281–H289.
4. Madden JA, Vadula MS, Kurup VP: Effects of hypoxia and other
vasoactive agents on pulmonary and cerebral artery smooth
muscle cells. Am J Physiol 1992, 263:L384–L393.
5. Murray TR, Chen L, Marshall BE, Macarak EJ: Hypoxic contraction of
cultured pulmonary vascular smooth muscle cells. Am J Respir
Cell Mol Biol 1990, 3:457–465.
6. Nelson MT, Quayle JM: Physiological roles and properties of potas-
sium channels in arterial smooth muscle. Am J Physiol 1995,
268:C799–C822.
7. Yuan X-J: Voltage-gated K+ currents regulate resting membrane
potential and [Ca2+]i in pulmonary arterial myocytes. Circ Res
1995,  77:370–378.
8. McMurtry IF, Davidson AB, Reeves JT, Grover RF: Inhibition of
hypoxic pulmonary vasoconstriction by calcium antagonists in
isolated rat lungs. Circ Res 1976, 38:99–104.
9. Gelband CH, Gelband H: Ca2+ release from intracellular stores is
an initial step in hypoxic pulmonary vasoconstriction of rat pul-
monary artery resistance vessels. Circulation 1997, 96:3647–3654.
10. Salvaterra CG, Goldman WF: Acute hypoxia increases cytosolic
calcium in cultured pulmonary arterial myocytes. Am J Physiol
1993,  264:L323–L328.
11. Evans AM, Osipenko ON, Gurney AM: Properties of a novel K+
• current that is active at resting potential in rabbit pulmonary artery 
smooth muscle cells. J Physiol (Lond) 1996, 496:407–420.
Identification of a non-activating, voltage-gated K+ current involved in the
regulation of resting membrane potential in rabbit PASMC.
12. Post JM, Gelband CH, Hume JR: [Ca2+]i inhibition of K+ channels in 
• canine pulmonary artery. Novel mechanism for hypoxia-induced 
membrane depolarization. Circ Res 1995, 77:131–139.
Demonstration that hypoxia-induced Ca2+ release triggers the inhibition of
voltage-gated K+ channels in canine PASMC.
13. Albarwani S, Robertson BE, Nye PC, Kozlowski RZ: Biophysical
properties of Ca2+- and Mg-ATP-activated K+ channels in pul-
monary arterial smooth muscle cells isolated from the rat. Pflugers
Arch 1994, 428:446–454.
14. Peng W, Hoidal JR, Farrukh IS: Role of a novel KCa opener in regu-
lating K+ channels of hypoxic human pulmonary vascular cells.
Am J Respir Cell Mol Biol 1999, 20:737–745.
15. Yuan X-J, Wang J, Juhaszova M, Golovina VA, Rubin LJ: Molecular
basis and function of voltage-gated K+ channels in pulmonary
arterial smooth muscle cells. Am J Physiol 1998, 274:L621–L635.
16. Post JM, Hume JR, Archer SL, Weir EK: Direct role for potassium 
•• channel inhibition in hypoxic pulmonary vasoconstriction. Am J 
Physiol 1992,  262:C882–C890.
First demonstration of reduction in K+ currents by hypoxia in PASMC.
17. Archer SL, Huang J, Henry T, Peterson D, Weir EK: A redox-based O2
sensor in rat pulmonary vasculature. Circ Res 1993, 73:1100–1112.
18. Osipenko ON, Evans AM, Gurney AM: Regulation of the resting 
•• potential of rabbit pulmonary artery myocytes by a low threshold, 
O2-sensing potassium current. Br J Pharmacol 1997, 120:1461–
1470.
Demonstration of a new O2-sensitive, voltage-gated K+ channel in rabbit
PASMC.
19. Yuan X-J, Goldman WF, Tod ML, Rubin LJ, Blaustein MP: Hypoxia 
•• reduces potassium currents in cultured rat pulmonary but not 
mesenteric arterial myocytes. Am J Physiol 1993, 264:L116–L1123.
Acute hypoxia inhibits a voltage-gated K+ current and causes membrane
depolarization in rat PASMC.
20. Patel AJ, Lazdunski M, Honore E: Kv2.1/Kv9.3, a novel ATP-depen-
•• dent delayed-rectifier K+ channel in oxygen-sensitive pulmonary 
artery myocytes. EMBO J 1997, 16:6615–6625.
Coexpression of Kv2.1 with Kv9.3 forms a heteromultimeric channel that is
active at the resting membrane potential of PASMC and is sensitive to
hypoxia.
21. England SK, Uebele VN, Kodali J, Bennett PB, Tamkun MM: A novel
K+ channel beta-subunit (hKvb b1.3) is produced via alternative
mRNA splicing. J Biol Chem 1995, 270:28531–28534.
22. Rettig J, Heinemann SH, Wunder F, Lorra C, Parcej DN, Dolly JO,
Pongs O: Inactivation properties of voltage-gated K+ channels
altered by presence of beta-subunit. Nature 1994, 369:289–294.
23. Conforti L, Bodi I, Nisbet JW, Millhorn DE: O2-sensitive K+ channels: 
• role of the Kv1.2 -subunit in mediating the hypoxic response. J 
Physiol (Lond) 2000, 524:783–793.
Kv1.2 is important in conferring oxygen sensitivity on K+ channels in PC12
cells.
24. Hulme JT, Coppock EA, Felipe A, Martens JR, Tamkun MM: Oxygen 
•• sensitivity of cloned voltage-gated K+ channels expressed in the 
pulmonary vasculature. Circ Res 1999, 85:489–497.
Kv1.2/Kv1.5 heteromeric channels are active in the voltage range of resting
membrane potential of PASMC and are inhibited by hypoxia.
25. Wang J, Juhaszova M, Rubin LJ, Yuan X-J: Hypoxia inhibits gene 
•• expression of voltage-gated K+ channel alpha subunits in pul-
monary artery smooth muscle cells. J Clin Invest 1997, 100:2347–
2353.
Prolonged hypoxia downregulates Kv1.2 and Kv1.5 mRNA and protein
expression in rat PASMC.
26. Archer SL, Souil E, Dinh-Xuan AT, Schremmer B, Mercier JC, El
Yaagoubi A, Nguyen-Huu L, Reeve HL, Hampl V: Molecular identifi-
cation of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1,
in hypoxic pulmonary vasoconstriction and control of resting
membrane potential in rat pulmonary artery myocytes. J Clin
Invest 1998,  101:2319–2330.
27. Osipenko ON, Tate RJ, Gurney AM: Potential role for Kv3.1b chan-
• nels as oxygen sensors. Circ Res 2000, 86:534–540.
Expression of Kv3.1b forms an O2-sensitive, voltage-gated K+ channel in
L929 cells.
http://respiratory-research.com/content/1/1/040
c
o
m
m
e
n
t
a
r
y
r
e
v
i
e
w
r
e
p
o
r
t
s
p
r
i
m
a
r
y
 
r
e
s
e
a
r
c
hRespiratory Research    Vol 1 No 1 Sweeney and Yuan
28. Perez-Garcia MT, Lopez-Lopez JR, Gonzalez C: Kvb b1.2 subunit co-
• expression in HEK293 cells confers O2 sensitivity to Kv4.2 but not 
to Shaker channels. J Gen Physiol 1999, 113:897–907.
Kvb1.2 confers O2 sensitivity on the voltage-gated K+ channels formed by
Kv4.2 a subunits in HEK293 cells.
29. Xu C, Lu Y, Tang G, Wang R: Expression of voltage-dependent K+
channel genes in mesenteric artery smooth muscle cells. Am J
Physiol 1999, 277:G1055–G1063.
30. Lopez-Barneo J, Pardal R, Montoro RJ, Smani T, Garcia-Hirschfeld J,
Urena J: K+ and Ca2+ channel activity and cytosolic [Ca2+] in
oxygen-sensing tissues. Respir Physiol 1999, 115:215–227.
31. Yuan X-J, Tod ML, Rubin LJ, Blaustein MP: Deoxyglucose and
reduced glutathione mimic effects of hypoxia on K+ and Ca2+ con-
ductances in pulmonary artery cells. Am J Physiol 1994, 267:L52–
L63.
32. Jiang C, Haddad GG: A direct mechanism for sensing low oxygen
levels by central neurons. Proc Natl Acad Sci USA 1994, 91:7198–
7201.
33. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC,
Schumacker PT: Mitochondrial reactive oxygen species trigger
hypoxia-induced transcription. Proc Natl Acad Sci USA 1998, 95:
11715–11720.
34. Cross AR, Henderson L, Jones OT, Delpiano MA, Hentschel J, Acker
H: Involvement of an NAD(P)H oxidase as a pO2 sensor protein in
the rat carotid body. Biochem J 1990, 272:743–747.
35. Berger MG, Vandier C, Bonnet P, Jackson WF, Rusch NJ: Intracellu-
lar acidosis differentially regulates KV channels in coronary and
pulmonary vascular muscle. Am J Physiol 1998, 275:H1351–
H1359.
36. McMurtry IF, Petrun MD, Reeves JT: Lungs from chronically hypoxic
rats have decreased pressor response to acute hypoxia. Am J
Physiol 1978,  235:H104–H109.
37. Smirnov SV, Robertson TP, Ward JP, Aaronson PI: Chronic hypoxia 
•• is associated with reduced delayed rectifier K+ current in rat pul-
monary artery muscle cells. Am J Physiol 1994, 266:H365–H370.
First demonstration that chronic hypoxia inhibitos voltage-gated K+ currents
and induces membrane depolarization in rat PASMC.
38. Shimoda LA, Sylvester JT, Sham JS: Chronic hypoxia alters effects
of endothelin and angiotensin on K+ currents in pulmonary arterial
myocytes. Am J Physiol 1999, 277:L431–L439.
39. Li KX, Fouty B, McMurtry IF, Rodman DM: Enhanced ETA-receptor-
mediated inhibition of KV channels in hypoxic hypertensive rat
pulmonary artery myocytes. Am J Physiol 1999, 277:H363–H370.
40. Bunn HF, Poyton RO: Oxygen sensing and molecular adaptation to
hypoxia. Physiol Rev 1996, 76:839–885.
41. Dhulipala PD, Kotlikoff MI: Cloning and characterization of the pro-
moters of the maxiK channel alpha and beta subunits. Biochim
Biophys Acta 1999, 1444:254–262.
42. Valverde P, Koren G: Purification and preliminary characterization
of a cardiac Kv1.5 repressor element binding factor. Circ Res
1999,  84:937–944.
43. Levitan ES, Gealy R, Trimmer JS, Takimoto K: Membrane depolariza-
tion inhibits Kv1.5 voltage-gated K+ channel gene transcription
and protein expression in pituitary cells. J Biol Chem 1995, 270:
6036–6041.
44. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK: Nitric
oxide and cGMP cause vasorelaxation by activation of a charybdo-
toxin-sensitive K channel by cGMP-dependent protein kinase.
Proc Natl Acad Sci USA 1994, 91:7583–7587.
45. Yuan X-J, Tod ML, Rubin LJ, Blaustein MP: NO hyperpolarizes pul-
monary artery smooth muscle cells and decreases the intracellu-
lar Ca2+ concentration by activating voltage-gated K+ channels.
Proc Natl Acad Sci USA 1996, 93:10489–10494.
46. Clapp LH, Turcato S, Hall S, Baloch M: Evidence that Ca2+-activated
K+ channels play a major role in mediating the vascular effects of
iloprost and cicaprost. Eur J Pharmacol 1998, 356:215–224.
47. DiCarlo VS, Chen SJ, Meng QC, Durand J, Yano M, Chen YF, Oparil
S:  ETA-receptor antagonist prevents and reverses chronic
hypoxia-induced pulmonary hypertension in rat. Am J Physiol
1995,  269:L690–L697.
48. Archer SL, Huang JM, Reeve HL, Hampl V, Tolarova S, Michelakis E,
Weir EK: Differential distribution of electrophysiologically distinct
myocytes in conduit and resistance arteries determines their
response to nitric oxide and hypoxia. Circ Res 1996, 78:431–442.
49. Clement-Chomienne O, Ishii K, Walsh MP, Cole WC: Identification,
cloning and expression of rabbit vascular smooth muscle Kv1.5
and comparison with native delayed rectifier K+ current. J Physiol
(Lond) 1999, 515:653–667.
Authors’ affiliation: Division of Pulmonary and Critical Care Medicine,
Department of Medicine, University of California, San Diego, California,
USA
Correspondence: Jason X-J Yuan, MD, PhD, Division of Pulmonary
and Critical Care Medicine, UCSD Medical Center, MC 8382, 
200 W Arbor Drive, San Diego, CA 92103-8382, USA. 
Tel: +1 619 543 2878; fax: +1 619 543 2929; 
e-mail: xiyuan@ucsd.edu